ESHAP protocol

Known as: Cisplatin/Cytarabine/Etoposide/Methylprednisolone, ARA-C/CDDP/MePRDL/VP-16, E-SHAP 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2018
051019902018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND The role of re-treatment with rituximab in aggressive B-cell lymphomas still needs to be defined. This study evaluated… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2005
2005
Summary:The ESHAP (etoposide, methylprednisolone, high-dose cytarabine, and cisplatin) regimen has been shown to be effective as… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2005
2005
High-dose therapy (HDT) is now recommended for patients under 60 years of age with chemosensitive relapsed aggressive non-Hodgkin… (More)
Is this relevant?
2002
2002
Treatment for patients with stage IV indolent lymphoma ranges from watchful waiting to intensive chemotherapy and stem cell… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • figure 1
Is this relevant?
2002
2002
BACKGROUND: One patient with B-cell Non-Hodgkin's Lymphoma developed severe hypomagnesaemia and tetany 15 days after the first… (More)
Is this relevant?
2000
2000
Cyclophosphamide 1.5 g m–2 followed by granulocyte colony-stimulating factor (G-CSF) is an effective peripheral blood stem cell… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1999
1999
BACKGROUND Refractory or relapsing Hodgkin's disease is associated with a poor prognosis. There is no widely accepted salvage… (More)
Is this relevant?
1996
1996
Intraocular lymphoma (IOL) is a rare form of non Hodgkin lymphoma (NHL); it has a poor prognosis and is frequently associated… (More)
Is this relevant?
1995
1995
PURPOSE We report the results of a prospective trial in which patients with relapsing non-Hodgkin's lymphomas were sequentially… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE This study attempted to determine the efficacy of the combination of etoposide (VP-16), methyl-prednisolone, and… (More)
Is this relevant?